1 Min Read
June 9 (Reuters) - WILSON THERAPEUTICS AB:
* WILSON THERAPEUTICS RECEIVES US ORPHAN DRUG DESIGNATION FOR WTX101 FOR THE TREATMENT OF ALS Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.